NSEDisclosure under SEBI Takeover RegulationsRegulatory3 Jul 2026
Mukka Proteins Limited
Disclosure under SEBI Takeover Regulations
Mukka Proteins Limited has submitted a disclosure under SEBI Takeover Regulations, confirming that promoters and promoter group have not made any encumbrance on shares held in the company during the financial year ended 31st March 2026.
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyLitigation1 Jul 2026
Mukka Proteins Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Mukka Proteins Limited has informed the Exchange about the pendency of a litigation/dispute that may impact the company. The company received an appellate order from the Commissioner of Income Tax (Appeals) that partly allowed the appeal by deleting additions to the income tax. However, the addition relating to alleged excess stock amounting to ₹7,54,55,608 has been sustained.
NSEAcquisition▼ NegativeM&A30 Jun 2026
Mukka Proteins Limited
Acquisition
Mukka Proteins Limited has informed the Exchange about further delay in acquisition of Mukka Proteins Vietnam Co., Ltd. due to delay in getting regulatory approvals in Vietnam.
NSETrading Window26 Jun 2026
Mukka Proteins Limited
Trading Window
Mukka Proteins Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1st, 2026, until 48 hours after the declaration of its Q2 FY2026-27 financial results.
NSEAcquisition▲ PositiveM&A25 Jun 2026
Mukka Proteins Limited
Acquisition
Mukka Proteins Limited has completed the acquisition of Delta Marine Products.